Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-30
1996-07-02
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548453, 548568, C07D20736, C07D207325, A61K 3140
Patent
active
055322662
ABSTRACT:
Novel arylacetamides of the formula I ##STR1## in which Q is R.sup.4 --CH(CH.sub.2 Z)--NA--, ##STR2## R.sup.1 is Ar, cycloalkyl with 3-7 C atoms or C.sub.4 -C.sub.8 -cycloalkyl-C.sub.1 -C.sub.7 -alkyl,
REFERENCES:
patent: 4192883 (1980-03-01), Cousse
patent: 4806547 (1989-02-01), Giardina et al.
patent: 5091392 (1992-02-01), Raddatz et al.
Barber et al., "A pharmacological profile of the novel, peripherally-selective .kappa.-opioid . . . ", Br. J. Pharmacol (1994), 113, pp. 1317-1327.
Tarayre, et al., Arzneim-Forsch./Drug Res., 33(II), No. 7, pp. 931-935, 1983.
Hendrickson et al, Organic Chemistry, 3rd Edition, p. 513, 1970.
CA78(9) 58099r, Clemence et al, FR 2113786 patent abstract, Aug. 1972.
CA77(11) 75024; Clemence et al, DE 2155906 patent abstract, May 1972.
Ackermann Karl-August
Barber Andrew
Bartoszyk Gerd
Gottschlich Rudolf
Greiner Hartmut
Ivy C. Warren
M. Mach D. Margaret
Merck Patent Gesellschaft mit beschrankter Haftung
LandOfFree
Acrylacetamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acrylacetamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acrylacetamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506774